Ingevity Corp Files 2024 10-K

Ticker: NGVT · Form: 10-K · Filed: Feb 19, 2025 · CIK: 1653477

Ingevity Corp 10-K Filing Summary
FieldDetail
CompanyIngevity Corp (NGVT)
Form Type10-K
Filed DateFeb 19, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: 10-K, annual-report, chemicals

TL;DR

Ingevity filed its 2024 10-K. Check financials for FY24.

AI Summary

Ingevity Corp filed its 2024 10-K on February 19, 2025, reporting on its fiscal year ending December 31, 2024. The company, incorporated in Delaware, operates in the Chemicals & Allied Products sector. Its principal executive offices are located at 4920 O'Hear Avenue, Suite 400, North Charleston, SC.

Why It Matters

This filing provides a comprehensive overview of Ingevity Corp's financial performance, operations, and risk factors for the fiscal year 2024, crucial for investors and stakeholders to assess the company's health and future prospects.

Risk Assessment

Risk Level: medium — The filing is a standard annual report and does not inherently indicate elevated risk without further analysis of its contents.

Key Numbers

Key Players & Entities

FAQ

What is the primary business of Ingevity Corp?

Ingevity Corp operates in the Chemicals & Allied Products sector, as indicated by SIC code 2800.

When did Ingevity Corp's fiscal year 2024 end?

Ingevity Corp's fiscal year 2024 ended on December 31, 2024.

Where is Ingevity Corp headquartered?

Ingevity Corp's principal business and mailing address is 4920 O'Hear Avenue, Suite 400, North Charleston, SC 29405.

What is the SEC file number for Ingevity Corp?

The SEC file number for Ingevity Corp is 001-37586.

On what date was this 10-K filing submitted?

This 10-K filing was submitted on February 19, 2025.

Filing Details

This Form 10-K (Form 10-K) was filed with the SEC on February 19, 2025 regarding Ingevity Corp (NGVT).

View full filing on EDGAR

View Full Filing

View this 10-K filing on SEC EDGAR

View on Read The Filing